<SEC-DOCUMENT>0001968582-23-000149.txt : 20230524
<SEC-HEADER>0001968582-23-000149.hdr.sgml : 20230524
<ACCEPTANCE-DATETIME>20230524115349
ACCESSION NUMBER:		0001968582-23-000149
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230524
DATE AS OF CHANGE:		20230524

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sana Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001770121
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39941
		FILM NUMBER:		23952663

	BUSINESS ADDRESS:	
		STREET 1:		188 EAST BLAINE STREET, SUITE 400
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		(206) 701-7914

	MAIL ADDRESS:	
		STREET 1:		188 EAST BLAINE STREET, SUITE 400
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Flagship Ventures Fund V, L.P.
		CENTRAL INDEX KEY:			0001627639
		IRS NUMBER:				611749444
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		ONE MEMORIAL DRIVE, 7TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-868-1888

	MAIL ADDRESS:	
		STREET 1:		ONE MEMORIAL DRIVE, 7TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <!-- Generated by Workiva -->
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001627639</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001770121</issuerCik>
      <issuerName>Sana Biotechnology, Inc</issuerName>
      <secFileNumber>001-39941</secFileNumber>
      <issuerAddress>
        <com:street1>188 East Blaine St, Ste 400</com:street1>
        <com:city>Seattle</com:city>
        <com:stateOrCountry>WA</com:stateOrCountry>
        <com:zipCode>98102</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>206-701-7914</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>FLAGSHIP VENTURES FUND V, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>J.P. Morgan Securities LLC</name>
        <address>
          <com:street1>390 Madison Avenue - 6th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10017</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>85334</noOfUnitsSold>
      <aggregateMarketValue>598191</aggregateMarketValue>
      <noOfUnitsOutstanding>191500944</noOfUnitsOutstanding>
      <approxSaleDate>05/24/2023</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>common</securitiesClassTitle>
      <acquiredDate>05/12/2017</acquiredDate>
      <natureOfAcquisitionTransaction>Venture Capital investment</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>85334</amountOfSecuritiesAcquired>
      <paymentDate>05/12/2017</paymentDate>
      <natureOfPayment>cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>05/24/2023</noticeDate>
      <signature>/s/ JPMS LLC as agent and attorney-in-fact for FLAGSHIP VENTURES FUND V, L.P.</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
